{"nct_id":"NCT03084471","title":"An Open-Label, Multi-Centre, Study to Assess the Safety of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies.","status":"COMPLETED","status_verified_date":"2022-12","start_date":"2017-06-05","start_date_type":"ACTUAL","primary_completion_date":"2020-03-31","primary_completion_date_type":"ACTUAL","completion_date":"2022-12-16","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["AZN"]}